Companies: 10,795·Total market cap: $144.5T
PLx Pharma Inc.

PLx Pharma Inc.

PLXPNASDAQHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$2534980
P/E Ratio
52W High$3.41
52W Low$0.009
Overview

PLx Pharma Inc. (PLXP) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · PLXP · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2021-122020-122019-122018-122017-12
Operating Activities
Net Income($46.13M)($15.21M)($20.50M)$0.90M($15.35M)
Depreciation & Amort.$0.21M$0.42M$0.16M$0.20M$0.03M
Stock-Based Comp.$2.88M$1.29M$0.88M$0.00M$0.00M
Change in Working Capital$5.41M($0.49M)$0.87M$0.25M($2.70M)
Net Cash from Operations($32.12M)($12.24M)($12.66M)($9.50M)($13.31M)
Investing Activities
Capital Expenditure$0.00M($0.10M)($0.24M)($0.65M)($0.54M)
Purchases of Investments$0.00M$0.00M$0.00M$0.00M$0.00M
Sales of Investments$0.00M$0.00M$0.00M$0.00M$0.00M
Net Cash from Investing$0.10M($0.10M)($0.23M)($0.65M)$11.24M
Financing Activities
Common Stock Repurchased$8.04M$1.74M$13.75M$0.00M$0.00M
Dividends Paid$0.00M$0.00M$0.00M$0.00M$0.00M
Debt Issued / Repaid$0.00M$0.00M$0.00M$0.00M$0.00M
Net Cash from Financing$78.97M$20.79M$12.64M$0.00M$26.41M
Free Cash Flow
Free Cash Flow($32.12M)($12.35M)($12.90M)($10.15M)($13.84M)
FCF Margin %(computed)-391.30%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M

Explore more PLx Pharma Inc. data

About PLx Pharma Inc. (PLXP) Cash Flow Statement

PLx Pharma Inc. generated operating cash flow of ($0.03B) and free cash flow of ($0.03B) for 2021 — a FCF margin of -391.30%. Capital expenditure was $0.00B.

Frequently asked questions

PLXP · 4 questions

PLx Pharma Inc. generated free cash flow of ($0.03B) for 2021, down 160.2% year-over-year.

PLXP free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10